OncoNano Medicine to Present at the American Association for Cancer Research (AACR) Annual Meeting 2022
March 10, 2022
SOUTHLAKE, Texas--(BUSINESS WIRE)--OncoNano Medicine, Inc. today announced two poster presentations at the American Association for Cancer Research (AACR) Annual Meeting 2022, taking place April 8-13, 2022 in New Orleans, Louisiana.
Full details of the presentations are listed below:
TITLE: Encapsulating therapeutic antibodies for tumor specific activation and delivery using a clinically validated pH-sensitive nanoparticle platform
PRESENTER: Jason Miller, Ph.D.
DATE: April 11, 2022
TIME: 1:30 – 5:00 PM CT
LOCATION: New Orleans Convention Center, Exhibit Halls D-H, Poster Section 20
TITLE: ONM-501: A polyvalent STING agonist for oncology immunotherapy
PRESENTER: Qingtai Su, Ph.D.
DATE: April 13, 2022
TIME: 9:00 AM – 12:30 PM CT
LOCATION: New Orleans Convention Center, Exhibit Halls D-H, Poster Section 38
About OncoNano Medicine
OncoNano Medicine is developing a new class of products that exploit pH as a biomarker to diagnose and treat cancer with high specificity. Our product candidates are designed to help patients across the continuum of cancer care and include solid tumor therapeutics, agents for real-time image-guided surgery and a platform of product candidates that activate and guide the body’s immune system to target cancer. Learn more at OncoNano.com.
Contacts
MacDougall Advisors
Lauren Arnold
781-235-3060
larnold@macdougall.bio
